nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Homicidal ideation—Varenicline—nicotine dependence	0.135	0.138	CcSEcCtD
Milnacipran—Anger—Varenicline—nicotine dependence	0.0475	0.0485	CcSEcCtD
Milnacipran—Night sweats—Varenicline—nicotine dependence	0.0315	0.0321	CcSEcCtD
Milnacipran—Suicidal ideation—Varenicline—nicotine dependence	0.0242	0.0247	CcSEcCtD
Milnacipran—Mania—Varenicline—nicotine dependence	0.0233	0.0238	CcSEcCtD
Milnacipran—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0225	0.023	CcSEcCtD
Milnacipran—Endocrine disorder—Varenicline—nicotine dependence	0.0205	0.0209	CcSEcCtD
Milnacipran—Pethidine—OPRM1—nicotine dependence	0.0195	1	CrCbGaD
Milnacipran—Aggression—Varenicline—nicotine dependence	0.0193	0.0197	CcSEcCtD
Milnacipran—Chest discomfort—Varenicline—nicotine dependence	0.0192	0.0196	CcSEcCtD
Milnacipran—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0188	0.0192	CcSEcCtD
Milnacipran—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0188	0.0192	CcSEcCtD
Milnacipran—Blood pressure increased—Varenicline—nicotine dependence	0.017	0.0173	CcSEcCtD
Milnacipran—Dry eye—Varenicline—nicotine dependence	0.0157	0.016	CcSEcCtD
Milnacipran—Renal failure acute—Varenicline—nicotine dependence	0.0133	0.0136	CcSEcCtD
Milnacipran—Libido decreased—Varenicline—nicotine dependence	0.0133	0.0136	CcSEcCtD
Milnacipran—Hot flush—Varenicline—nicotine dependence	0.0132	0.0134	CcSEcCtD
Milnacipran—Menopausal symptoms—Varenicline—nicotine dependence	0.0131	0.0133	CcSEcCtD
Milnacipran—Thirst—Varenicline—nicotine dependence	0.0129	0.0132	CcSEcCtD
Milnacipran—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0122	0.0125	CcSEcCtD
Milnacipran—Migraine—Varenicline—nicotine dependence	0.0121	0.0124	CcSEcCtD
Milnacipran—Irritability—Varenicline—nicotine dependence	0.0118	0.012	CcSEcCtD
Milnacipran—Urinary retention—Varenicline—nicotine dependence	0.0117	0.012	CcSEcCtD
Milnacipran—Liver function test abnormal—Varenicline—nicotine dependence	0.0114	0.0116	CcSEcCtD
Milnacipran—Dry skin—Varenicline—nicotine dependence	0.0113	0.0115	CcSEcCtD
Milnacipran—Breast disorder—Varenicline—nicotine dependence	0.0111	0.0114	CcSEcCtD
Milnacipran—Abdominal distension—Varenicline—nicotine dependence	0.0107	0.0109	CcSEcCtD
Milnacipran—Angina pectoris—Varenicline—nicotine dependence	0.0104	0.0106	CcSEcCtD
Milnacipran—Pollakiuria—Varenicline—nicotine dependence	0.00984	0.01	CcSEcCtD
Milnacipran—Erectile dysfunction—Varenicline—nicotine dependence	0.00981	0.01	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00942	0.0096	CcSEcCtD
Milnacipran—Hepatobiliary disease—Varenicline—nicotine dependence	0.00898	0.00916	CcSEcCtD
Milnacipran—Hallucination—Varenicline—nicotine dependence	0.00848	0.00865	CcSEcCtD
Milnacipran—Hypoaesthesia—Varenicline—nicotine dependence	0.00848	0.00865	CcSEcCtD
Milnacipran—Urinary tract disorder—Varenicline—nicotine dependence	0.00842	0.00859	CcSEcCtD
Milnacipran—Oedema peripheral—Varenicline—nicotine dependence	0.0084	0.00857	CcSEcCtD
Milnacipran—Connective tissue disorder—Varenicline—nicotine dependence	0.00838	0.00854	CcSEcCtD
Milnacipran—Urethral disorder—Varenicline—nicotine dependence	0.00836	0.00852	CcSEcCtD
Milnacipran—Erythema multiforme—Varenicline—nicotine dependence	0.00806	0.00822	CcSEcCtD
Milnacipran—Eye disorder—Varenicline—nicotine dependence	0.00797	0.00813	CcSEcCtD
Milnacipran—Cardiac disorder—Varenicline—nicotine dependence	0.00791	0.00807	CcSEcCtD
Milnacipran—Angiopathy—Varenicline—nicotine dependence	0.00773	0.00789	CcSEcCtD
Milnacipran—Mediastinal disorder—Varenicline—nicotine dependence	0.00768	0.00784	CcSEcCtD
Milnacipran—Chills—Varenicline—nicotine dependence	0.00765	0.0078	CcSEcCtD
Milnacipran—Mental disorder—Varenicline—nicotine dependence	0.00747	0.00762	CcSEcCtD
Milnacipran—Malnutrition—Varenicline—nicotine dependence	0.00742	0.00757	CcSEcCtD
Milnacipran—Flatulence—Varenicline—nicotine dependence	0.00731	0.00746	CcSEcCtD
Milnacipran—Dysgeusia—Varenicline—nicotine dependence	0.00727	0.00741	CcSEcCtD
Milnacipran—Vision blurred—Varenicline—nicotine dependence	0.00699	0.00713	CcSEcCtD
Milnacipran—Tremor—Varenicline—nicotine dependence	0.00695	0.00709	CcSEcCtD
Milnacipran—Agitation—Varenicline—nicotine dependence	0.00682	0.00696	CcSEcCtD
Milnacipran—Syncope—Varenicline—nicotine dependence	0.00666	0.00679	CcSEcCtD
Milnacipran—Palpitations—Varenicline—nicotine dependence	0.00656	0.00669	CcSEcCtD
Milnacipran—Loss of consciousness—Varenicline—nicotine dependence	0.00652	0.00665	CcSEcCtD
Milnacipran—Convulsion—Varenicline—nicotine dependence	0.00643	0.00656	CcSEcCtD
Milnacipran—Hypertension—Varenicline—nicotine dependence	0.00641	0.00653	CcSEcCtD
Milnacipran—Chest pain—Varenicline—nicotine dependence	0.00632	0.00644	CcSEcCtD
Milnacipran—Anxiety—Varenicline—nicotine dependence	0.0063	0.00642	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00627	0.0064	CcSEcCtD
Milnacipran—Dry mouth—Varenicline—nicotine dependence	0.00618	0.0063	CcSEcCtD
Milnacipran—Infection—Varenicline—nicotine dependence	0.00602	0.00614	CcSEcCtD
Milnacipran—Shock—Varenicline—nicotine dependence	0.00596	0.00608	CcSEcCtD
Milnacipran—Nervous system disorder—Varenicline—nicotine dependence	0.00594	0.00606	CcSEcCtD
Milnacipran—Thrombocytopenia—Varenicline—nicotine dependence	0.00593	0.00605	CcSEcCtD
Milnacipran—Tachycardia—Varenicline—nicotine dependence	0.00591	0.00603	CcSEcCtD
Milnacipran—Skin disorder—Varenicline—nicotine dependence	0.00588	0.006	CcSEcCtD
Milnacipran—Hyperhidrosis—Varenicline—nicotine dependence	0.00586	0.00597	CcSEcCtD
Milnacipran—Anorexia—Varenicline—nicotine dependence	0.00577	0.00589	CcSEcCtD
Milnacipran—Hypotension—Varenicline—nicotine dependence	0.00566	0.00577	CcSEcCtD
Milnacipran—Insomnia—Varenicline—nicotine dependence	0.00548	0.00559	CcSEcCtD
Milnacipran—Dyspnoea—Varenicline—nicotine dependence	0.0054	0.00551	CcSEcCtD
Milnacipran—Somnolence—Varenicline—nicotine dependence	0.00538	0.00549	CcSEcCtD
Milnacipran—Dyspepsia—Varenicline—nicotine dependence	0.00533	0.00544	CcSEcCtD
Milnacipran—Decreased appetite—Varenicline—nicotine dependence	0.00527	0.00537	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00523	0.00533	CcSEcCtD
Milnacipran—Fatigue—Varenicline—nicotine dependence	0.00522	0.00533	CcSEcCtD
Milnacipran—Constipation—Varenicline—nicotine dependence	0.00518	0.00528	CcSEcCtD
Milnacipran—Gastrointestinal pain—Varenicline—nicotine dependence	0.00495	0.00505	CcSEcCtD
Milnacipran—Urticaria—Varenicline—nicotine dependence	0.00481	0.00491	CcSEcCtD
Milnacipran—Body temperature increased—Varenicline—nicotine dependence	0.00479	0.00488	CcSEcCtD
Milnacipran—Abdominal pain—Varenicline—nicotine dependence	0.00479	0.00488	CcSEcCtD
Milnacipran—Hypersensitivity—Varenicline—nicotine dependence	0.00446	0.00455	CcSEcCtD
Milnacipran—Asthenia—Varenicline—nicotine dependence	0.00435	0.00443	CcSEcCtD
Milnacipran—Pruritus—Varenicline—nicotine dependence	0.00429	0.00437	CcSEcCtD
Milnacipran—Diarrhoea—Varenicline—nicotine dependence	0.00414	0.00423	CcSEcCtD
Milnacipran—Dizziness—Varenicline—nicotine dependence	0.00401	0.00408	CcSEcCtD
Milnacipran—Vomiting—Varenicline—nicotine dependence	0.00385	0.00393	CcSEcCtD
Milnacipran—Rash—Varenicline—nicotine dependence	0.00382	0.00389	CcSEcCtD
Milnacipran—Dermatitis—Varenicline—nicotine dependence	0.00382	0.00389	CcSEcCtD
Milnacipran—Headache—Varenicline—nicotine dependence	0.00379	0.00387	CcSEcCtD
Milnacipran—Nausea—Varenicline—nicotine dependence	0.0036	0.00367	CcSEcCtD
